Tenaya Therapeutics TNYA 深 沪
等待开盘 08-10 09:30:00 美东时间
0.7268
+0.001
+0.14%
华盛通- 最 高0.8184
- 今 开0.7315
- 成交量 156.25万股
- 最 低 0.725
- 昨 收 0.7258
- 总市值 3.00万
- 52周最高 2.35
- 市盈率 静 --
- 换手率 3782.27%
- 52周最低 0.5316
- 委 比 42.46%
- 总股本 4.13万
- 历史最高 32.00
- 量 比 0.68
- 振 幅 12.87%
- 历史最低 0.36
- 每 手 1
- 风险率 0.36%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Tenaya Therapeutics' Gene Therapy Data Highlights Early Heart Rhythm Improvements
Tenaya reported early RIDGE-1 data showing reduced arrhythmias and favorable safety for TN-401 in PKP2-related ARVC patients.
05-15 22:11
Tenaya Therapeutics Stock Jumps After New Alnylam Deal
Tenaya Therapeutics stock jumps after announcing a research collaboration with Alnylam worth up to $1.13 billion in milestone payments.
03-06 02:35
Tenaya Stock Plunges After $60 Million Equity Offering
Heart disease-focused Tenaya Therapeutics falls on high volume after pricing a $60 million offering and releasing new TN-401 data, while the FDA clears the TN-201 trial hold.
2025-12-13 02:56
S&P 500 Down 1%; Broadcom Earnings Top Views
U.S. stocks traded lower midway through trading, with the Nasdaq Composite fall...
2025-12-13 01:17
Tenaya Therapeutics Reports Interim RIDGE‑1 Trial Data For TN‑401 Gene Therapy In PKP2‑Mutated ARVC
TN-401 was Well Tolerated at 3E13 vg/kg dose Robust Transduction and Demonstrated Increases in PKP2 Protein Levels in First Two Patients at Week 8Clinically Meaningful Reductions in Arrhythmia Burden Observed in
2025-12-12 05:05
Tenaya Therapeutics Q3 EPS $(0.12) Beats $(0.15) Estimate
Tenaya Therapeutics (NASDAQ:TNYA) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 22.58 percent. This is a 60 percent increase over losses of $(0.30) per share from
2025-11-10 20:15
HC Wainwright & Co. Maintains Buy on Tenaya Therapeutics, Lowers Price Target to $5
HC Wainwright & Co. analyst Joseph Pantginis maintains Tenaya Therapeutics (NASDAQ:TNYA) with a Buy and lowers the price target from $18 to $5.
2025-03-11 18:31
Tenaya Therapeutics Q4 2024 GAAP EPS $(0.28) Beats $(0.31) Estimate
Tenaya Therapeutics (NASDAQ:TNYA) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.31) by 9.68 percent. This is a 30 percent increase over losses of $(0.40) per share from
2025-03-11 04:08
万春医药盘中异动 股价大跌5.83%报2.10美元
北京时间2024年11月05日03时10分，万春医药（BYSI.us）股票出现波动，股价快速下挫5.83%。截至发稿，该股报2.10美元/股，成交量1.5265万股，换手率0.04%，振幅3.14%。 最近的财报数据显示，该股实现营业收入1000000.00美元，净利润-7.26百万美元，每股收益-0.19美元，毛利--，市盈率-5.32倍。 机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。 万春医药股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Neurogene Inc.、Tenaya Therapeutics, Inc.、Disc Medicine, Inc....
2024-11-05 03:10
